(SPLR) Notification on Corporate Action "Reverse Stock Split/Change in nominal value" - BioLine Rx Ltd ORD SHS ADR (depositary receipts ISIN US09071M2052)
Corporate Action Details
Corporate Action Reference
999536
Corporate Action Type Code
SPLR
Corporate Action Type
Reverse Stock Split/Change in nominal value
Mandatory indicator
MAND Mandatory
Security Details
Corporate Action Security Reference
Issuer
Security Name
Category
NSD Code
ISIN
Underlying Security Issuer
Underlying Security Type
Ratio ( Number of DR/ Number of Underlying Securities)
999536D627
BNY Mellon
BioLine Rx Ltd ORD SHS ADR
American depository receipt
US09071M2052
US09071M2052
BioLine Rx Ltd
shares ordinary
1 : 15
Corporate Action Details
Effective Date
30 jan 2025
Record Date
Unknown
Ex-Dividend or Distribution Date/Time
Unknown
National Settlement Depository (NSD) notifies that the information regarding Reverse
Stock Split/Change in nominal value has been received from International Settlement
and Clearing Organization. Detailed information regarding this corporate action event will be provided to holders
who have balances of these securities on their safekeeping accounts with NSD.
If you have any questions related to this communication, please contact your account managers at NSD by telephone: +7 495 956-27-90 or +7 495 956-27-91.
Print page
NSD processes cookies to personalise its services and make www.nsddata.ru more user-friendly.
By clicking the «Accept»
button, you consent to the processing of cookies.
You can refuse the processing of cookies by changing your browser settings.